Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 2

Results: 37
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 2, p. e396, doi. 10.1634/theoncologist.2019-0515
    By:
    • Warner, Blake;
    • Baer, Alan
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response.

    Published in:
    Oncologist, 2020, v. 25, n. 2, p. e198, doi. 10.1634/theoncologist.2019-0603
    By:
    • Valiakhmetova, Andge;
    • Gorelyshev, Sergey;
    • Konovalov, Alexander;
    • Trunin, Yuri;
    • Savateev, Alexander;
    • Kram, David E.;
    • Severson, Eric;
    • Hemmerich, Amanda;
    • Edgerly, Claire;
    • Duncan, Daniel;
    • Britt, Nicholas;
    • Huang, Richard S.P.;
    • Elvin, Julia;
    • Miller, Vincent;
    • Ross, Jeffrey S.;
    • Gay, Laurie;
    • McCorkle, Joshua;
    • Rankin, Andrew;
    • Erlich, Rachel L.;
    • Chudnovsky, Yakov
    Publication type:
    Article
    21
    22
    23

    Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor‐Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care‐BC): A Randomized Controlled Phase III Trial.

    Published in:
    Oncologist, 2020, v. 25, n. 2, p. e223, doi. 10.1634/theoncologist.2019-0382
    By:
    • Niikura, Naoki;
    • Nakatukasa, Katsuhiko;
    • Amemiya, Takeshi;
    • Watanabe, Ken‐ichi;
    • Hata, Hironobu;
    • Kikawa, Yuichiro;
    • Taniike, Naoki;
    • Yamanaka, Takashi;
    • Mitsunaga, Sachiyo;
    • Nakagami, Kazuhiko;
    • Adachi, Moriyasu;
    • Kondo, Naoto;
    • Shibuya, Yasuyuki;
    • Hayashi, Naoki;
    • Naito, Mariko;
    • Kashiwabara, Kosuke;
    • Yamashita, Toshinari;
    • Umeda, Masahiro;
    • Mukai, Hirofumi;
    • Ota, Yoshihide
    Publication type:
    Article
    24
    25

    CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement.

    Published in:
    Oncologist, 2020, v. 25, n. 2, p. 112, doi. 10.1634/theoncologist.2019-0356
    By:
    • Da Vià, Matteo Claudio;
    • Solimando, Antonio Giovanni;
    • Garitano‐Trojaola, Andoni;
    • Barrio, Santiago;
    • Munawar, Umair;
    • Strifler, Susanne;
    • Haertle, Larissa;
    • Rhodes, Nadine;
    • Teufel, Eva;
    • Vogt, Cornelia;
    • Lapa, Constantin;
    • Beilhack, Andreas;
    • Rasche, Leo;
    • Einsele, Hermann;
    • Kortüm, K. Martin
    Publication type:
    Article
    26
    27

    A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.

    Published in:
    Oncologist, 2020, v. 25, n. 2, p. e311, doi. 10.1634/theoncologist.2019-0309
    By:
    • Macchia, Gabriella;
    • Lazzari, Roberta;
    • Colombo, Nicoletta;
    • Laliscia, Concetta;
    • Capelli, Giovanni;
    • D'Agostino, Giuseppe Roberto;
    • Deodato, Francesco;
    • Maranzano, Ernesto;
    • Ippolito, Edy;
    • Ronchi, Sara;
    • Paiar, Fabiola;
    • Scorsetti, Marta;
    • Cilla, Savino;
    • Ingargiola, Rossana;
    • Huscher, Alessandra;
    • Cerrotta, Anna Maria;
    • Fodor, Andrei;
    • Vicenzi, Lisa;
    • Russo, Donatella;
    • Borghesi, Simona
    Publication type:
    Article
    28
    29
    30
    31

    The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B‐Cell Lymphoma.

    Published in:
    Oncologist, 2020, v. 25, n. 2, p. e321, doi. 10.1634/theoncologist.2019-0233
    By:
    • Ali, Sahra;
    • Kjeken, Rune;
    • Niederlaender, Christiane;
    • Markey, Greg;
    • Saunders, Therese S.;
    • Opsata, Mona;
    • Moltu, Kristine;
    • Bremnes, Bjørn;
    • Grønevik, Eirik;
    • Muusse, Martine;
    • Håkonsen, Gro D.;
    • Skibeli, Venke;
    • Kalland, Maria Elisabeth;
    • Wang, Ingrid;
    • Buajordet, Ingebjørg;
    • Urbaniak, Ania;
    • Johnston, John;
    • Rantell, Khadija;
    • Kerwash, Essam;
    • Schuessler‐Lenz, Martina
    Publication type:
    Article
    32
    33
    34

    A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1‐3 M0 Gastric Cancer (OGSG 1601).

    Published in:
    Oncologist, 2020, v. 25, n. 2, p. 119, doi. 10.1634/theoncologist.2019-0601
    By:
    • Terazawa, Tetsuji;
    • Matsuyama, Jin;
    • Goto, Masahiro;
    • Kawabata, Ryohei;
    • Endo, Shunji;
    • Imano, Motohiro;
    • Fujita, Shoichiro;
    • Akamaru, Yusuke;
    • Taniguchi, Hirokazu;
    • Tatsumi, Mitsutoshi;
    • Lee, Sang‐Woong;
    • Kurisu, Yoshitaka;
    • Kawakami, Hisato;
    • Kurokawa, Yukinori;
    • Shimokawa, Toshio;
    • Sakai, Daisuke;
    • Kato, Takeshi;
    • Fujitani, Kazumasa;
    • Satoh, Taroh
    Publication type:
    Article
    35

    Withholding the Introduction of Anti‐Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild‐Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study).

    Published in:
    Oncologist, 2020, v. 25, n. 2, p. e266, doi. 10.1634/theoncologist.2019-0328
    By:
    • Palmieri, Lola‐Jade;
    • Mineur, Laurent;
    • Tougeron, David;
    • Rousseau, Benoît;
    • Granger, Victoire;
    • Gornet, Jean‐Marc;
    • Smith, Denis;
    • Lievre, Astrid;
    • Galais, Marie‐Pierre;
    • Doat, Solene;
    • Pernot, Simon;
    • Bignon‐Bretagne, Anne‐Laure;
    • Metges, Jean‐Philippe;
    • Baba‐Hamed, Nabil;
    • Michel, Pierre;
    • Obled, Stéphane;
    • Vitellius, Carole;
    • Bouche, Olivier;
    • Saban‐Roche, Léa;
    • Buecher, Bruno
    Publication type:
    Article
    36
    37